| The sock of domestic pharma major, hit a low of Rs 700 before closing at Rs 711.80, down 3.41 per cent. More than 76 thousand shares changed hands at the counter on BSE on Friday. |
| Other pharma stocks were also impacted and ended lower. Cipla was down 6 per cent to Rs 234.40, while Ranbaxy ended 3.43 per cent lower to Rs 951.95. |
| Analysts said, pharma stocks continue to witness selling amid concerns that the results of pharma companies may not be very encouraging on account of MRP-based excise duty structure. |
| For Dr Reddy's, which had been looking to win the case, it is a big blow because the blockbuster drug would have bring the company healthy profits after several dismal quarters, said an analyst. The drug has global sales of $4.42 billion last year. |
Explore Business Standard